These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23550894)

  • 1. Longitudinal changes in high-density lipoprotein cholesterol and cardiovascular events in older adults.
    Araujo AB; Chiu GR; Christian JB; Kim HY; Evans WJ; Clark RV
    Clin Endocrinol (Oxf); 2014 May; 80(5):662-70. PubMed ID: 23550894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time dependent changes in high density lipoprotein cholesterol and cardiovascular risk.
    Milwidsky A; Kivity S; Kopel E; Klempfner R; Berkovitch A; Segev S; Sidi Y; Goldenberg I; Maor E
    Int J Cardiol; 2014 May; 173(2):295-9. PubMed ID: 24681020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.
    Laitinen DL; Manthena S
    Adv Ther; 2010 Apr; 27(4):233-44. PubMed ID: 20437214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus.
    Nichols GA; Vupputuri S; Rosales AG
    Am J Cardiol; 2011 Oct; 108(8):1124-8. PubMed ID: 21985949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
    Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between HDL-C concentration and risk for a major cardiovascular event.
    Laitinen DL; Manthena S; Webb S
    Curr Med Res Opin; 2010 Apr; 26(4):933-41. PubMed ID: 20163298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms associated with cholesterol and risk of cardiovascular events.
    Kathiresan S; Melander O; Anevski D; Guiducci C; Burtt NP; Roos C; Hirschhorn JN; Berglund G; Hedblad B; Groop L; Altshuler DM; Newton-Cheh C; Orho-Melander M
    N Engl J Med; 2008 Mar; 358(12):1240-9. PubMed ID: 18354102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly.
    de Freitas EV; Brandão AA; Pozzan R; Magalhães ME; Fonseca F; Pizzi O; Campana E; Brandão AP
    Arch Gerontol Geriatr; 2011; 52(2):217-22. PubMed ID: 20417975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm.
    Sever PS; Poulter NR; Chang CL; Thom SA; Hughes AD; Welsh P; Sattar N;
    J Am Coll Cardiol; 2013 Aug; 62(8):717-29. PubMed ID: 23948514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between lipoprotein cholesterol and future cardiovascular disease and mortality in older adults: a Korean nationwide longitudinal study.
    Kim SH; Son KY
    Lipids Health Dis; 2021 Jan; 20(1):3. PubMed ID: 33407561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A prospective study of serum high density lipoprotein cholesterol, cardiovascular and cerebrovascular risk in a Chinese muti-provinces cohort].
    Liu Q; Zhao D; Wang W; Liu J; Sun JY; Liu J
    Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):272-6. PubMed ID: 18843947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study.
    Tohidi M; Mohebi R; Cheraghi L; Hajsheikholeslami F; Aref S; Nouri S; Azizi F; Hadaegh F
    Clin Biochem; 2013 Jun; 46(9):716-21. PubMed ID: 23531403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging.
    Karlamangla AS; Singer BH; Reuben DB; Seeman TE
    J Am Geriatr Soc; 2004 Apr; 52(4):487-94. PubMed ID: 15066061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.